Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (61-70 of 497) with videos related to

Pageof 50
Sort By:
Tumori|March 29, 2014
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastasesGiuseppe Procopio, Elena Verzoni, Pamela Biondani, et al.
Tumori|February 18, 2015
Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumorsSara Pusceddu, Filippo de Braud, Laura Concas, et al.
Hemasphere|July 11, 2020
Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed InfectionsPaolo Corradini, Giorgia Gobbi, Filippo de Braud, et al.
Biomedicine Hub|January 29, 2020
The Three-Way Pendulum of Healthcare InnovationDenis Horgan, Filippo de Braud, Bengt Jonsson, et al.
Oncoimmunology|November 2, 2013
Biological insights into BRAF<sup>V600</sup> mutations in melanoma patient: Not mere therapeutic targetsGiuseppina Improta, Giuseppe Pelosi, Elena Tamborini, et al.
International Journal of Molecular Sciences|September 5, 2019
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical PracticeAlessandra Raimondi, Giovanni Randon, Pierangela Sepe, et al.
The Oncologist|May 22, 2020
Are Cyclin-Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?Sara Pusceddu, Francesca Corti, Massimo Milione, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Clinical Interventions in Aging|January 14, 2015
Bevacizumab treatment in the elderly patient with metastatic colorectal cancerMaria Di Bartolomeo, Claudia Maggi, Francesca Ricchini, et al.
British Journal of Clinical Pharmacology|June 26, 2014
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trialsRoberto Iacovelli, Filippo Pietrantonio, Antonella Palazzo, et al.
Pageof 50

Showing results (61-70 of 497) with videos related to

Sort By:
Pageof 50
Tumori|March 29, 2014
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastasesGiuseppe Procopio, Elena Verzoni, Pamela Biondani, et al.
Tumori|February 18, 2015
Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumorsSara Pusceddu, Filippo de Braud, Laura Concas, et al.
Hemasphere|July 11, 2020
Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed InfectionsPaolo Corradini, Giorgia Gobbi, Filippo de Braud, et al.
Biomedicine Hub|January 29, 2020
The Three-Way Pendulum of Healthcare InnovationDenis Horgan, Filippo de Braud, Bengt Jonsson, et al.
Oncoimmunology|November 2, 2013
Biological insights into BRAF<sup>V600</sup> mutations in melanoma patient: Not mere therapeutic targetsGiuseppina Improta, Giuseppe Pelosi, Elena Tamborini, et al.
International Journal of Molecular Sciences|September 5, 2019
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical PracticeAlessandra Raimondi, Giovanni Randon, Pierangela Sepe, et al.
The Oncologist|May 22, 2020
Are Cyclin-Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?Sara Pusceddu, Francesca Corti, Massimo Milione, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Clinical Interventions in Aging|January 14, 2015
Bevacizumab treatment in the elderly patient with metastatic colorectal cancerMaria Di Bartolomeo, Claudia Maggi, Francesca Ricchini, et al.
British Journal of Clinical Pharmacology|June 26, 2014
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trialsRoberto Iacovelli, Filippo Pietrantonio, Antonella Palazzo, et al.
Pageof 50